Paper Details

  1. Home
  2. Paper Details

Comparing the effectiveness of selective laser trabeculoplasty with topical medication as initial treatment (the Glaucoma Initial Treatment Study): study protocol for a randomised controlled trial.

Author: AngGhee Soon, CassonRobert, ConstantinouMarios, CrowstonJonathan, FenwickEva K, FinkelsteinEric, GoldbergIvan, HealeyPaul, LamoureuxEcosse L, McintoshRachel, PesudovsKonrad, ThomasRavi, XieJing

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Glaucoma is a leading cause of blindness, affecting millions worldwide. While eye drops are the usual first treatment, they have drawbacks like cost, side effects, and difficulty sticking to the treatment. Laser treatment has been shown to be as effective as eye drops in lowering pressure in the eye, but more research is needed to compare these options from the patient and economic perspectives.
Paper Details　
Original Abstract of the Article :
Glaucoma is the leading cause of irreversible blindness in the world. Estimated to affect 60 million people worldwide, this figure is expected to rise to 80 million by 2020. Untreated, glaucoma leads to visual decay and eventually to blindness, and can significantly reduce quality of life. First-lin...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567808/

データ提供：米国国立医学図書館（NLM）

Glaucoma Treatment: A Crossroads in the Desert of Vision Loss

We're navigating the vast desert of ophthalmology, focusing on the treatment of glaucoma, a leading cause of blindness. This study is like a group of researchers standing at a crossroads, comparing two different approaches to treating glaucoma: selective laser trabeculoplasty and topical medication. They aim to determine the most effective and cost-effective option for patients. The study is a quest to find the best path to preserve vision in a world where millions suffer from glaucoma.

Finding the Right Path: Laser or Medication for Glaucoma?

This study is designed to compare the effectiveness and cost-effectiveness of selective laser trabeculoplasty and topical medication for treating glaucoma. The researchers want to determine which treatment modality is the best choice for patients, taking into account both clinical outcomes and patient preferences. It's like choosing the right path through the desert, considering factors like terrain, resources, and the desired destination.

Preserving Vision: A Journey Through the Desert of Glaucoma

This study is a critical step in finding the most effective treatment for glaucoma, a disease that can lead to irreversible blindness. It's a journey through the desert of vision loss, searching for ways to preserve and protect sight. It's a reminder that we must continue to invest in research and development to find better treatments for this debilitating disease.

Dr.Camel's Conclusion

The desert of glaucoma is a challenging landscape, but with ongoing research and innovation, we can find better ways to treat this disease and protect our precious vision. This study is an important step in this journey, and its findings will have a significant impact on the lives of millions of people worldwide.
Date :
  1. Date Completed 2016-06-10
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

26362541

DOI: Digital Object Identifier

PMC4567808

Related Literature

Article Analysis
・Effective treatment of glaucoma
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.